Inventor · disambiguated record
David C. Kaslow
Also filed as: KASLOW DAVID C
16 granted patents·9 pending applications·119 citations·filing 1990–2014
93Inventor score
Top patents by PatentIndex Score
25 records- 0191US6733993B2Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modificationsMERCK & CO INC·Filed 2001·Granted May 11, 2004·38 cites·57 claims
- 0286US7598362B2Hepatitis C virus vaccineMERCK & CO INC·Filed 2002·Granted Oct 6, 2009·12 cites·50 claims
- 0382US10350289B2Methods of immunization with varicella zoster virus antigenMERCK SHARP & DOHME·Filed 2014·Granted Jul 16, 2019·4 cites·23 claims
- 0470US8142794B2Hepatitis C virus vaccineEMINI EMILIO A·Filed 2009·Granted Mar 27, 2012·1 cites·27 claims
- 0569US7407658B2Vaccines for blocking transmission of plasmodium vivaxUS HEALTH·Filed 2006·Granted Aug 5, 2008·3 cites·17 claims
- 0664US8530234B2Hepatitis C virus vaccineKASLOW DAVID C·Filed 2009·Granted Sep 10, 2013·0 cites·3 claims
- 0756US6780417B2Transmission blocking immunogen from malariaUS HEALTH·Filed 1995·Granted Aug 24, 2004·19 cites·4 claims
- 0856US2008274132A1Vaccines for blocking transmission of plasmodium vivaxUS GOV HEALTH & HUMAN SERV·Filed 2008·Application pending·0 cites
- 0955US2005070017A1Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modificationsFiled 2003·Application pending·0 cites
- 1051US5753238ATarget antigens of transmission blocking antibodies for malaria parasitesUS ARMY·Filed 1995·Granted May 19, 1998·5 cites·12 claims
- 1151US2008254059A1Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced TherebyBETT ANDREW J·Filed 2006·Application pending·0 cites
- 1249US2004191222A1Adenovirus serotype 34 vectors, nucleic acids and virus produced therebyFiled 2003·Application pending·0 cites
- 1349US2004101957A1Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol.nef and modificationsFiled 2001·Application pending·0 cites
- 1449US2004106194A1Methods for propagating adenovirus and virus produced therebyFiled 2003·Application pending·0 cites
- 1548US2004185555A1Adenovirus serotype 24 vectors, nucleic acids and virus produced therebyFiled 2003·Application pending·0 cites
- 1647US2007054395A1Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modificationsEMINI EMILIO A·Filed 2006·Application pending·0 cites
- 1745US6316000B1Cloning and expression of plasmodium falciparum transmission-blocking target antigen, PFS230US HEALTH·Filed 1997·Granted Nov 13, 2001·4 cites·11 claims
- 1844US5198347ADna encoding plasmodium vivax and plasmodium knowlesi duffy receptorUS HEALTH·Filed 1990·Granted Mar 30, 1993·9 cites·10 claims
- 1943US5853739ATransmission-blocking vaccine against malariaUS HEALTH·Filed 1994·Granted Dec 29, 1998·9 cites·13 claims
- 2042US5527700ATarget antigens of transmission blocking antibodies for malaria parasitesUS ARMY·Filed 1993·Granted Jun 18, 1996·3 cites·3 claims
- 2140US2007077257A1Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modificationsEMINI EMILIO A·Filed 2006·Application pending·0 cites
- 2237US5217898AExpression of the P. falciparum transmission-blocking antigen in yeastUS HEALTH·Filed 1991·Granted Jun 8, 1993·5 cites·5 claims
- 2335US5733772ACloning and expression of Plasmodium falciparum transmission blocking target antigen, Pfs230US ARMY·Filed 1994·Granted Mar 31, 1998·2 cites·13 claims
- 2434US5541292APlasmodium vivax and Plasmodium knowlesi Duffy receptorUS HEALTH·Filed 1992·Granted Jul 30, 1996·3 cites·3 claims
- 2531US7192934B1Vaccines for blocking transmission of Plasmodium vivaxUS HEALTH·Filed 1998·Granted Mar 20, 2007·2 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →